Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2018-2023 by Players, Regions, Product Types & Applications
The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.
This report offers an overview of the market trends, drivers, and barriers with respect to the Benign Prostatic Hyperplasia (BPH) Treatment Devices market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Benign Prostatic Hyperplasia (BPH) Treatment Devices market by by Procedure Type, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.
This report focuses Global market, it covers details as following:
Key Players
Endo International (US)
Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)
Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Procedure Type
Laser Based Procedure
Other Energy Based Procedure
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Key Consumer
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
This report offers an overview of the market trends, drivers, and barriers with respect to the Benign Prostatic Hyperplasia (BPH) Treatment Devices market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Benign Prostatic Hyperplasia (BPH) Treatment Devices market by by Procedure Type, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.
This report focuses Global market, it covers details as following:
Key Players
Endo International (US)
Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)
Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Main types of products
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Procedure Type
Laser Based Procedure
Other Energy Based Procedure
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Key Consumer
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
CHAPTER ONE METHODOLOGY AND DATA SOURCE
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
CHAPTER TWO BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET OVERVIEW
2.1 Market Coverage
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales Volume Revenue and Price 2012-2017
CHAPTER THREE BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY KEY PLAYERS 2013-2018
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2013-2018
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Key Players 2013-2018
3.3 Global Key Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Product Model and Market Performance
3.4 Global Key Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Target Consumers and Market Performance
CHAPTER FOUR BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY REGIONS 2013-2018
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018
4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Regions 2013-2018
4.4 North America
4.4.1 United States
4.4.2 Canada
4.5 Latin America
4.5.1 Mexico
4.5.2 Brazil
4.5.3 Argentina
4.5.4 Others in Latin America
4.6 Europe
4.6.1 Germany
4.6.2 United Kingdom
4.6.3 France
4.6.4 Italy
4.6.5 Spain
4.6.6 Russia
4.6.7 Netherland
4.6.8 Others in Europe
4.7 Asia & Pacific
4.7.1 China
4.7.2 Japan
4.7.3 India
4.7.4 Korea
4.7.5 Australia
4.7.6 Southeast Asia
4.7.6.1 Indonesia
4.7.6.2 Thailand
4.7.6.3 Philippines
4.7.6.4 Vietnam
4.7.6.5 Singapore
4.7.6.6 Malaysia
4.7.6.7 Others in Southeast Asia
4.8 Africa & Middle East
4.8.1 South Africa
4.8.2 Egypt
4.8.3 Turkey
4.8.4 Saudi Arabia
4.8.5 Iran
4.8.6 Others in Africa & Middle East
CHAPTER FIVE BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET BY PRODUCT TYPES
5.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by Procedure Type 2013-2018
5.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type 2013-2018
5.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type 2013-2018
5.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Procedure Type 2013-2018
5.1.4 Laser Based Procedure
5.1.5 Other Energy Based Procedure
5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by 2013-2018
CHAPTER SIX GLOBAL KEY PLAYERS PROFILE
6.1 Endo International (US)
6.1.1 Endo International (US) Company Details and Competitors
6.1.2 Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.1.4 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.2 Karl Storz (Germany)
6.2.1 Karl Storz (Germany) Company Details and Competitors
6.2.2 Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.2.4 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.3 Medtronic (US)
6.3.1 Medtronic (US) Company Details and Competitors
6.3.2 Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.3.4 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.4 Siemens (Germany)
6.4.1 Siemens (Germany) Company Details and Competitors
6.4.2 Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.4.4 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.5 Lumenis (Israel)
6.5.1 Lumenis (Israel) Company Details and Competitors
6.5.2 Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.5.4 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.6 Olympus (Japan)
6.6.1 Olympus (Japan) Company Details and Competitors
6.6.2 Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.6.4 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.7 Urologix (US)
6.7.1 Urologix (US) Company Details and Competitors
6.7.2 Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.7.4 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.8 NeoTract (US)
6.8.1 NeoTract (US) Company Details and Competitors
6.8.2 NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.8.4 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.9 Boston Scientific (US)
6.9.1 Boston Scientific (US) Company Details and Competitors
6.9.2 Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.9.4 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.10 Urotech (Germany)
6.10.1 Urotech (Germany) Company Details and Competitors
6.10.2 Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.10.4 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.11 Toshiba (Japan)
6.12 Baxter International (US)
CHAPTER SEVEN BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY APPLIANCE 2013-2018
7.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance 2013-2018
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Specialty Clinics
7.5 Others
7.6 Consuming Habit and Preference
CHAPTER EIGHT INDUSTRY CHAIN AND SUPPLY CHAIN
8.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment
CHAPTER NINE GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2023)
9.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD) Forecast (2018-2023)
9.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Regions (2018-2023)
9.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2018-2023)
9.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
9.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
CHAPTER TEN DEVELOPMENT TREND AND RESEARCH CONCLUSION
10.1 Development Trend
10.2 Research Conclusion
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
CHAPTER TWO BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET OVERVIEW
2.1 Market Coverage
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales Volume Revenue and Price 2012-2017
CHAPTER THREE BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY KEY PLAYERS 2013-2018
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2013-2018
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Key Players 2013-2018
3.3 Global Key Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Product Model and Market Performance
3.4 Global Key Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Target Consumers and Market Performance
CHAPTER FOUR BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY REGIONS 2013-2018
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions 2013-2018
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions 2013-2018
4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Regions 2013-2018
4.4 North America
4.4.1 United States
4.4.2 Canada
4.5 Latin America
4.5.1 Mexico
4.5.2 Brazil
4.5.3 Argentina
4.5.4 Others in Latin America
4.6 Europe
4.6.1 Germany
4.6.2 United Kingdom
4.6.3 France
4.6.4 Italy
4.6.5 Spain
4.6.6 Russia
4.6.7 Netherland
4.6.8 Others in Europe
4.7 Asia & Pacific
4.7.1 China
4.7.2 Japan
4.7.3 India
4.7.4 Korea
4.7.5 Australia
4.7.6 Southeast Asia
4.7.6.1 Indonesia
4.7.6.2 Thailand
4.7.6.3 Philippines
4.7.6.4 Vietnam
4.7.6.5 Singapore
4.7.6.6 Malaysia
4.7.6.7 Others in Southeast Asia
4.8 Africa & Middle East
4.8.1 South Africa
4.8.2 Egypt
4.8.3 Turkey
4.8.4 Saudi Arabia
4.8.5 Iran
4.8.6 Others in Africa & Middle East
CHAPTER FIVE BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET BY PRODUCT TYPES
5.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by Procedure Type 2013-2018
5.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type 2013-2018
5.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type 2013-2018
5.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Procedure Type 2013-2018
5.1.4 Laser Based Procedure
5.1.5 Other Energy Based Procedure
5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices, by 2013-2018
CHAPTER SIX GLOBAL KEY PLAYERS PROFILE
6.1 Endo International (US)
6.1.1 Endo International (US) Company Details and Competitors
6.1.2 Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.1.4 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.2 Karl Storz (Germany)
6.2.1 Karl Storz (Germany) Company Details and Competitors
6.2.2 Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.2.4 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.3 Medtronic (US)
6.3.1 Medtronic (US) Company Details and Competitors
6.3.2 Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.3.4 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.4 Siemens (Germany)
6.4.1 Siemens (Germany) Company Details and Competitors
6.4.2 Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.4.4 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.5 Lumenis (Israel)
6.5.1 Lumenis (Israel) Company Details and Competitors
6.5.2 Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.5.4 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.6 Olympus (Japan)
6.6.1 Olympus (Japan) Company Details and Competitors
6.6.2 Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.6.4 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.7 Urologix (US)
6.7.1 Urologix (US) Company Details and Competitors
6.7.2 Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.7.4 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.8 NeoTract (US)
6.8.1 NeoTract (US) Company Details and Competitors
6.8.2 NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.8.4 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.9 Boston Scientific (US)
6.9.1 Boston Scientific (US) Company Details and Competitors
6.9.2 Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.9.4 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.10 Urotech (Germany)
6.10.1 Urotech (Germany) Company Details and Competitors
6.10.2 Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
6.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
6.10.4 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Revenue Price Cost and Gross Margin
6.11 Toshiba (Japan)
6.12 Baxter International (US)
CHAPTER SEVEN BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES BY APPLIANCE 2013-2018
7.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance 2013-2018
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Specialty Clinics
7.5 Others
7.6 Consuming Habit and Preference
CHAPTER EIGHT INDUSTRY CHAIN AND SUPPLY CHAIN
8.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment
CHAPTER NINE GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2023)
9.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD) Forecast (2018-2023)
9.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Regions (2018-2023)
9.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2018-2023)
9.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
9.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
CHAPTER TEN DEVELOPMENT TREND AND RESEARCH CONCLUSION
10.1 Development Trend
10.2 Research Conclusion
LIST OF TABLES AND FIGURES
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Key Players (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2018
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players 2013-2018
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Procedure Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Procedure Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Procedure Type (2013-2018)
Table Top Players of Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
Figure Global Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Top Players of Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
Figure Global Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by (2013-2018)
Table Endo International (US) Company Details and Competitors
Table Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Karl Storz (Germany) Company Details and Competitors
Table Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Medtronic (US) Company Details and Competitors
Table Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Siemens (Germany) Company Details and Competitors
Table Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Lumenis (Israel) Company Details and Competitors
Table Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Olympus (Japan) Company Details and Competitors
Table Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Urologix (US) Company Details and Competitors
Table Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table NeoTract (US) Company Details and Competitors
Table NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Boston Scientific (US) Company Details and Competitors
Table Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Urotech (Germany) Company Details and Competitors
Table Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Toshiba (Japan) Company Details and Competitors
Table Baxter International (US) Company Details and Competitors
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Appliance (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance in 2017
Figure Global Hospitals Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Specialty Clinics Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Others Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Trend Forecast (2018-2023)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Regions (2018-2023)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Procedure Type in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Key Players 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Key Players (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Key Players 2018
Table Global Key Players Key Product Model and Market Performance
Table Global Key Players Key Target Consumers and Market Performance
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Regions in 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2018
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players 2013-2018
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Asia & Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Regions (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Regions (2013-2018)
Table Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Key Players (2013-2018)
Figure Africa & Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Procedure Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Procedure Type in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Procedure Type (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Procedure Type in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Procedure Type (2013-2018)
Table Top Players of Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
Figure Global Laser Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Top Players of Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Products List
Figure Global Other Energy Based Procedure Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by in 2017
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by (2013-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by in 2016
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by (2013-2018)
Table Endo International (US) Company Details and Competitors
Table Endo International (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Karl Storz (Germany) Company Details and Competitors
Table Karl Storz (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Medtronic (US) Company Details and Competitors
Table Medtronic (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Siemens (Germany) Company Details and Competitors
Table Siemens (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Lumenis (Israel) Company Details and Competitors
Table Lumenis (Israel) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Olympus (Japan) Company Details and Competitors
Table Olympus (Japan) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Urologix (US) Company Details and Competitors
Table Urologix (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table NeoTract (US) Company Details and Competitors
Table NeoTract (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Boston Scientific (US) Company Details and Competitors
Table Boston Scientific (US) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Urotech (Germany) Company Details and Competitors
Table Urotech (Germany) Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Models and Performance
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Business SWOT Analysis and Forecast
Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales(Million Unit) and Growth Rate (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share (%) in Global (2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Revenue(Million USD) and Growth Rate (%)(2013-2018)
Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share (%) in Global (2013-2018)
Table Toshiba (Japan) Company Details and Competitors
Table Baxter International (US) Company Details and Competitors
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Appliance (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Appliance in 2017
Figure Global Hospitals Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Specialty Clinics Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Others Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Trend Forecast (2018-2023)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Regions (2018-2023)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Share Forecast by Regions in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Application in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Procedure Type (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Procedure Type in 2023
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by (2018-2023)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by in 2023
